Solid Biosciences Inc. (SLDB)

Solid Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	210.63	80.24	74.02	155.38	119.14	154.74
Short-Term Investments	96.29	68.69	49.63	58.34	88.64	-
Cash & Short-Term Investments	306.92	148.92	123.64	213.72	207.78	154.74
Cash Growth	48.94%	20.45%	-42.15%	2.86%	34.27%	85.27%
Receivables	-	-	-	-	0.11	-
Prepaid Expenses	3.36	1.65	2.11	3	8.71	1.48
Other Current Assets	3.13	6.73	3.98	2.91	6.02	2.67
Total Current Assets	313.41	157.3	129.73	219.64	222.61	158.9
Property, Plant & Equipment	28.2	29.04	33.16	38.61	7.6	11.73
Other Long-Term Assets	2.29	2.32	2.04	2.01	2.16	0.54
Total Assets	343.9	188.66	164.94	260.25	232.38	171.17
Accounts Payable	6.44	4.24	2.03	3.24	4.46	3.27
Accrued Expenses	14.58	19.85	10.16	16.69	9.53	8.64
Current Portion of Leases	2.96	3.02	2.32	2.57	1.5	2.21
Current Unearned Revenue	-	-	-	-	8.08	10.36
Other Current Liabilities	4.8	3.15	-	0.01	0.04	-
Total Current Liabilities	28.78	30.26	14.52	22.51	23.6	24.48
Long-Term Leases	20.66	21.16	23.94	25.98	0.57	2.94
Long-Term Unearned Revenue	-	-	-	-	-	10.36
Other Long-Term Liabilities	-	-	-	0.1	-	1.3
Total Liabilities	49.44	51.42	38.46	48.59	24.17	39.08
Common Stock	0.08	0.04	0.02	0.02	0.01	0.09
Additional Paid-In Capital	1,117	920.61	785.2	774.45	685.01	536.57
Retained Earnings	-822.73	-783.45	-658.75	-562.74	-476.76	-404.57
Comprehensive Income & Other	0	0.05	0.02	-0.07	-0.05	-
Total Common Equity	294.46	137.25	126.48	211.67	208.21	132.09
Shareholders' Equity	294.46	137.25	126.48	211.67	208.21	132.09
Total Liabilities & Equity	343.9	188.66	164.94	260.25	232.38	171.17
Total Debt	23.63	24.18	26.27	28.55	2.06	5.15
Net Cash (Debt)	283.29	124.74	97.38	185.18	205.72	149.59
Net Cash Growth	57.17%	28.11%	-47.41%	-9.98%	37.52%	95.66%
Net Cash Per Share	5.92	3.06	4.90	21.75	28.90	43.20
Filing Date Shares Outstanding	77.52	77.49	37.76	19.57	7.36	5.68
Total Common Shares Outstanding	77.49	40.47	20.39	19.56	7.36	5.66
Working Capital	284.63	127.05	115.22	197.13	199.01	134.42
Book Value Per Share	3.80	3.39	6.20	10.82	28.30	23.34
Tangible Book Value	294.46	137.25	126.48	211.67	208.21	132.09
Tangible Book Value Per Share	3.80	3.39	6.20	10.82	28.30	23.34
Machinery	-	16.1	17.92	17.96	11.37	10.27
Construction In Progress	-	0.88	0.41	1.72	1.49	1.33
Leasehold Improvements	-	0.47	0.48	0.38	4.71	4.71

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q